Company: SPRB
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059288
Chunk: 69

Company: SPRUCE BIOSCIENCES, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 69
---
 there is any material nonpublic information (“MNPI”) about the Company when determining the timing of stock option grants and does not seek to time the award of stock options in relation to the Company’s public disclosure of MNPI. The Company has not timed the release of MNPI for the purpose of affecting the value of executive compensation.

<div align='center'>45</div>

Director Compensation The following table sets forth information for the fiscal year ended December 31, 2024 concerning the compensation paid to all of our non-employee directors. Dr. Szwarcberg, our Chief Executive Officer did not receive additional compensation in connection with his service as a director, and therefore is not included in the Director Compensation table below. See the section titled “Executive Compensation” for more information regarding the compensation earned by Dr. Szwarcberg. Director Compensation for Fiscal 2024

| Name                       | Fees Earned or Paid in Cash ($) | Option Awards ($)(1) | All Other Compensation ($) | Total ($) |
| Tiba Aynechi, Ph.D.        |                          50,000 |               19,224 |                          — |    69,224 |
| Percival Barretto-Ko       |                          47,500 |               19,224 |                          — |    66,724 |
| Michael Grey               |                          70,000 |               19,224 |                          — |    89,224 |
| Bali Muralidhar, Ph.D.     |                          45,000 |               19,224 |                          — |    64,224 |
| Niall O’Donnell, Ph.D. (2) |                          18,642 |                    — |                          — |    18,642 |
| Daniel Spiegelman          |                          59,000 |               19,224 |                          — |    78,224 |
| Camilla Simpson, M.Sc.     |                          53,577 |               19,224 |                          — |    72,801 |
| Kirk Ways, M.D., Ph.D. (3) |                          48,000 |               19,224 |                      3,750 |    70,974 |

(1) Amounts shown in this column do not reflect dollar amounts actually received by non-employee directors. Instead, these amounts reflect the aggregate grant date fair value of each stock option granted computed in accordance with the provisions of FASB ASC Topic 718. Ass